Novartis: Leading a Global Enterprise Harvard Case Solution & Analysis

Novartis, the planet's top healthcare business, was fashioned in 1996 out of a merger of two quite different, mid-grade Switzerland-based pharma companies. The case traces the business evolution over the past 17 years, as it transformed into a truly global enterprise with 127,000 employees of 153 nationalities in 140 countries creating $56.7 billion in 2012 revenues and $9.6 billion in net income, making the business one of the world's largest and most lucrative companies.

Novartis Leading a Global Enterprise Case Study Solution

CEO since 2010, Joe Jimenez had taken over from airy legacy CEO Daniel Vasella and one of the architects of the amalgamation. He understood that Novartis needed to make sure it had the correct strategy, structure, talent and spirit to live up to its dreams and the global health care environment would create intense challenges for Novartis in the years ahead.

PUBLICATION DATE: May 27, 2013 PRODUCT #: 413096-HCB-ENG

This is just an excerpt. This case is about STRATEGY & EXECUTION

Novartis: Leading a Global Enterprise Case Solution Other Similar Case Solutions like

Novartis: Leading a Global Enterprise

Share This